Literature DB >> 11897428

Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles.

Yvette N Konan1, Robert Gurny, Eric Allémann.   

Abstract

The feasibility of producing sterile and freeze-dried polyester nanoparticles was investigated. Various poly(D,L-lactide-co-glycolide) and poly(D,L-lactide) were selected as biodegradable polymers. Using the salting-out procedure, process parameters were optimized to obtain sub-200 nm particles. After purification, the nanoparticle suspensions containing different lyoprotectants were sterilized by filtration. Freeze-drying was performed using vials covered with 0.22 microm membrane filters in order to preserve the suspensions from bacterial contamination. Sterility was assessed on the final product according to pharmacopoeial requirements using the membrane filtration method. With all polymers tested, sub-200 nm particles could be obtained. Nanoparticles with a size as low as 102 nm were prepared with good reproducibility and narrow size distribution. Upon freeze-drying, it appeared that complete redispersion of all types of polyester nanoparticles could be obtained in presence of the lyoprotectants tested such as saccharides while aggregation was observed without lyoprotectant. Sterility testing showed no microbial contamination indicating that sterile nanoparticulate formulations have been achieved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897428     DOI: 10.1016/s0378-5173(01)00944-9

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  33 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 2.  Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.

Authors:  Nitesh K Kunda; Satyanarayana Somavarapu; Stephen B Gordon; Gillian A Hutcheon; Imran Y Saleem
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

3.  Encapsulation of omega 3-6-9 fatty acids-rich oils using protein-based emulsions with spray drying.

Authors:  C Chang; Michael T Nickerson
Journal:  J Food Sci Technol       Date:  2018-06-19       Impact factor: 2.701

4.  The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers.

Authors:  Irène Brigger; Laurence Armand-Lefevre; Pierre Chaminade; Madeleine Besnard; Yohan Rigaldie; Alain Largeteau; Antoine Andremont; Luc Grislain; Gérard Demazeau; Patrick Couvreur
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

5.  Lyophilized oral sustained release polymeric nanoparticles of nateglinide.

Authors:  Mohammad Kaleemuddin; Prathima Srinivas
Journal:  AAPS PharmSciTech       Date:  2012-12-11       Impact factor: 3.246

6.  The effect of cryoprotection on the use of PLGA encapsulated iron oxide nanoparticles for magnetic cell labeling.

Authors:  Kevin S Tang; Sarah M Hashmi; Erik M Shapiro
Journal:  Nanotechnology       Date:  2013-03-04       Impact factor: 3.874

7.  PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.

Authors:  Li Mu; Si-Shen Feng
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

8.  Effect of the Freezing Step in the Stability and Bioactivity of Protein-Loaded PLGA Nanoparticles Upon Lyophilization.

Authors:  Pedro Fonte; Fernanda Andrade; Cláudia Azevedo; João Pinto; Vítor Seabra; Marco van de Weert; Salette Reis; Bruno Sarmento
Journal:  Pharm Res       Date:  2016-07-21       Impact factor: 4.200

9.  Effect of sugars, surfactant, and tangential flow filtration on the freeze-drying of poly(lactic acid) nanoparticles.

Authors:  Samuli Hirsjärvi; Leena Peltonen; Jouni Hirvonen
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

10.  Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells.

Authors:  Cheng Jin; Ling Bai; Hong Wu; Wenjie Song; Guozhen Guo; Kefeng Dou
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.